Panion & Bf Biotech Inc. (TPE:1760)

Market Cap	5.50B -26.2%
Revenue (ttm)	2.06B +1.7%
Net Income	190.17M +52.7%
EPS	2.21 +52.4%
Shares Out	85.74M
PE Ratio	29.00
Forward PE	n/a
Dividend	1.80 (2.81%)
Ex-Dividend Date	Jun 12, 2025

Volume	149,896
Average Volume	167,274
Open	64.80
Previous Close	64.00
Day's Range	63.30 - 64.80
52-Week Range	56.00 - 89.90
Beta	-0.05
RSI	59.99
Earnings Date	May 11, 2026

About Panion & Bf Biotech

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygien...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1976
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1760

Financial Performance

In 2025, Panion & Bf Biotech's revenue was 2.06 billion, an increase of 1.66% compared to the previous year's 2.03 billion. Earnings were 190.17 million, an increase of 52.72%.